In Brief
Sloan et al. developed a method for generating and purifying astrocytes from 3D cerebral cortical spheroids derived from human pluripotent cells. Long-term culture (20 months in vitro) and direct comparison to human primary cells reveal transcriptional and functional astrocyte maturation.
SUMMARY
There is significant need to develop physiologically relevant models for investigating human astrocytes in health and disease. Here, we present an approach for generating astrocyte lineage cells in a three-dimensional (3D) cytoarchitecture using human cerebral cortical spheroids (hCSs) derived from pluripotent stem cells. We acutely purified astrocyte-lineage cells from hCSs at varying stages up to 20 months in vitro using immunopanning and cell sorting and performed high-depth bulk and single-cell RNA sequencing to directly compare them to purified primary human brain cells. We found that hCS-derived glia closely resemble primary human fetal astrocytes and that, over time in vitro, they transition from a predominantly fetal to an increasingly mature astrocyte state. Transcriptional changes in astrocytes are accompanied by alterations in phagocytic capacity and effects on neuronal calcium signaling. These findings suggest that hCS-derived astrocytes closely resemble primary human astrocytes and can be used for studying development and modeling disease.
INTRODUCTION
Astrocytes comprise the most numerous cell type in the mammalian brain, yet we understand remarkably little about their development and physiological functions. Their juxtaposition to neuronal synapses explains many of their passive roles in the central nervous system (CNS), such as neurotransmitter recycling. Recent evidence, however, suggests that astrocytes also play active roles (Freeman and Rowitch, 2013) , including the control of synapse formation (Allen et al., 2012; Christopherson et al., 2005) , function (Eroglu et al., 2009; Tsai et al., 2012) , and elimination . Because of technical limitations, human astrocytes have received particularly little study. Recently, Zhang et al. (2016) reported that human astrocytes exist in at least two distinct stages: a fetal, proliferative, astrocyte progenitor cell (APC) state and an adult, non-proliferative, mature state. Several thousand genes are differentially expressed between fetal and adult human astrocytes , and many of these genes have been implicated in functional processes such as synapse formation (SPARCL1). Interestingly, in humans, the majority of mature astrocyte markers increase in expression during a time window extending throughout gestation until early postnatal development, which correlates with synapse density in the human cerebral cortex (Huttenlocher, 1979; Huttenlocher et al., 1982) and is thought to be critical for neuropsychiatric disease development. Therefore, elucidating the program underlying human astrocyte maturation and the ability to recapitulate these complex processes in human cellular models are a prerequisite for better understanding astrocyte development and function as well as the role of glia in brain disorders.
Unfortunately, investigating human astrocyte maturation within primary brain tissue is challenging; sample availability is sparse, particularly for critical developmental time periods such as late gestation or early postnatal stages. Human induced pluripotent stem cells (iPSCs) provide a unique platform to investigate neural development in vitro (Dolmetsch and Geschwind, 2011; Paş ca et al., 2014; Tabar and Studer, 2014) and to elucidate mechanisms of astrocyte development and dysfunction. To date, several groups have developed methods for generating astrocytes from iPSCs in two-dimensional (2D)/monolayer cultures (Emdad et al., 2012; Juopperi et al., 2012; Krencik and Ullian, 2013; Krencik and Zhang, 2011; Roybon et al., 2013; Shaltouki et al., 2013) , but these methods have limitations, especially in maintaining long-term cultures and non-reactive states in vitro.
To address these issues, we used a 3D differentiation approach that we previously developed for generating cerebral cortex-like structures (Paş ca et al., 2015) and leveraged the unique ability of these cultures to be maintained for long-term in vitro (20 months and beyond) to study their transcriptional and functional maturation. In these floating 3D neural cultures, named human cortical spheroids (hCSs), astrocyte lineage cells are generated spontaneously among a network of cortical neurons. The hCSs grow up to 4 mm in diameter and recapitulate key features of in vivo cortical development (Paş ca et al., 2015) , such as the presence of cortical lamination, abundant synaptogenesis, and robust spontaneous electrical activity. We repurposed strategies for isolating primary human neural and glial cells using immunopanning to purify astrocyte lineage cells directly from hCSs and compared the transcriptional profile of these cells to primary astrocytes isolated from the fetal and adult CNS. We maintained hCSs in long-term cultures up to 590 days in vitro and performed a time series of single-cell RNA sequencing (RNA-seq) to capture the dynamics of astrocyte differentiation in vitro over a long time window. This enabled us to ask whether astrocyte lineage cells within hCSs mature over time and whether this process is associated with cell-autonomous (synapse phagocytosis) and non-cell-autonomous (calcium signals in neurons) effects.
RESULTS

Generation and Purification of Astrocyte Lineage Cells from iPSC-Derived hCSs
To generate human astrocytes from human pluripotent stem cells in 3D cultures, we derived hCSs using a previously established approach (Paş ca et al., 2015) . hCSs are specified and maintained in floating conditions on low attachment and can be either cryosectioned for immunostaining or dissociated into single-cell suspensions for 2D culture, fluorescent-activated cell sorting (FACS), and other downstream analyses (Figure 1A) . As previously described (Birey et al., 2017; Deverman et al., 2016; Paş ca et al., 2015; Paş ca, 2016) , immunostainings on hCS cryosections for glial fibrillary acidic protein (GFAP) revealed abundant astrocyte-like cells that were distributed throughout the parenchyma, and 2D culture of dissociated hCSs showed GFAP-expressing cells with characteristic morphological features of astrocytes ( Figures 1B and 1C) . (I) PCA using the top two principal components and showing bulk RNA-seq of primary human fetal and adult CNS cell type samples along with hCS-derived neurons and astrocytes. The top 5,000 over-dispersed genes were used for analysis. hCS-derived cells are labeled by in vitro differentiation stage (d, day); 3-15 hCSs were collected from two iPSC lines across 18 differentiation experiments.
We refer to these GFAP-expressing cells as astrocyte lineage cells, an umbrella term that encompasses multiple stages of astrocyte differentiation, which may include radial glia (RG), outer radial glia (oRG), astrocyte progenitor cells (APCs), and mature astrocytes.
To purify astrocyte lineage cells from hCSs, we adapted our existing protocols for immunopanning primary human fetal and adult brain tissue . Immunopanning involves passing a single-cell suspension of dissociated tissue over a series of cell culture plates coated with antibodies directed against cell-type-specific antigens. As few as one hCS can be used for immunopanning, with a yield prior to immunopanning of about 500,000-1,000,000 live cells per hCS. Our immunopanning protocol consisted of an anti-Thy1 (Thy1 or CD90) antibody to bind neurons and an anti-hepatic and glial cell adhesion molecule (HepaCAM) antibody to bind astrocytes ( Figure 1D ). The advantage of using the cell adhesion glycoprotein HepaCAM for immunopanning is that the HEPACAM gene is enriched in astrocytes, but it is not as highly expressed by radial glia . hCSs contain only neural ectoderm derivatives and therefore do not require depletion of myeloid or vascular populations during the purification protocol as compared to primary brain tissue samples. After binding to antibody-coated plates, the cells of interest were either collected via trypsinization for subsequent culture in 2D or directly scraped off the plate to extract RNA for transcriptional profiling.
To verify the purity of the immunopanning process in hCSs, we cultured immunopanned hCS-derived neurons and astrocyte lineage cells in monolayer for 7 days and immunostained with antibodies against b-tubulin class III (TUBB3 or TUJ1) to identify neurons and anti-GFAP to identify glial cells . Whereas unpurified cultures of dissociated hCSs contained both GFAP-and TUJ1-expressing cells, the immunopanned populations were enriched for either neurons (Thy1-panned) or astrocyte lineage cells (HepaCAM-panned), respectively. In line with our previous findings (Paş ca et al., 2015) , immunopanning of hCSs with the anti-Thy1 antibody isolated numerous neurons as early as 40 days of differentiation in vitro, whereas HepaCAM immunopanning became increasingly efficient after 100 days of differentiation in vitro. This is suggestive of in vivo cell lineage progression in the human dorsal pallium, as well as the delayed onset of astrocyte generation, which typically begins only after the substantive portion of neurogenesis is complete (Freeman and Rowitch, 2013; Sloan and Barres, 2014) .
RNA-Seq Transcriptional Profiling of hCS-Derived Astrocyte Lineage Cells and Comparison to Primary Human Cells
Because GFAP is present in both astrocytes and radial glia in the developing mammalian brain and is often undetected in some mature astrocytes (Middeldorp et al., 2010; Oberheim et al., 2009 ), we used RNA-seq to verify the level of expression of a series of well-established neuronal and astrocyte markers (Cahoy et al., 2008; Lovatt et al., 2007; Zhang et al., 2016) in HepaCAM-isolated cells as compared to neurons isolated from hCSs. For example, we found high expression of the water transporter Aquaporin-4 (AQP4), the transcription factor SOX9, and the glial high-affinity glutamate transporter (SLC1A3) in hCSderived astrocyte lineage cells, but not in hCS-derived neurons, which instead showed high expression of neuronal markers such as TBR1, SYN1, and L1CAM ( Figure 1H ). These findings were consistent across hCSs derived from multiple iPSC lines at various time points and in independent differentiation experiments, as indicated by previous work with this differentiation platform (Paş ca et al., 2015) .
We next wanted to investigate the transcriptome level fidelity of hCS-derived cells as compared to primary human astrocytes and neurons. We leveraged our primary human RNA-seq transcriptome datasets , which include bulk samples of purified forebrain fetal astrocytes, postnatal astrocytes, fetal neurons, postnatal neurons, oligodendrocytes, endothelial cells, and microglia/macrophages, and directly compared these to our hCS-derived samples across multiple in vitro differentiation stages (from day 100 to day 450). hCSs can be maintained in floating conditions in ultra-low attachment plates for long periods of time (beyond 25 months in our experience); even after hundreds of days in vitro, hCSs were intact, retained a spherical morphology ( Figure S1A ), and displayed high cell viability (>90%) after dissociation (Figures S1B and S1C Figure 1I ; Figure S1G ). This division could be further appreciated from the degree of correlation between hCS-derived and fetal astrocytes (R 2 = 0.83, Pearson correlation, p < 0.0001) versus the correlation between hCS-derived astrocytes and other human CNS cell types (R 2 = 0.61, Pearson correlation, p < 0.001) ( Figure S1H ).
Astrocyte Maturation within hCSs
We next asked whether, over longer time periods in vitro, astrocytes within hCSs might undergo a transition from a fetal to a more mature state. We first established a time window for when the transition from fetal to mature astrocytes might occur in vivo. We utilized our existing datasets of human astrocytes to identify the top 100 fetal and top 100 mature astrocyte genes that demarcate these two maturation states and that were not expressed in other CNS cell types. We then asked how expression of these astrocyte-specific markers varied in transcriptomic datasets obtained from human brain tissue across numerous regions and developmental periods (Kang et al., 2011) . This comparison revealed a consistent trend, in which the expression of the top 100 mature astrocyte markers started to increase as early as 50-100 days postconception, accelerating around birth and continuing to increase throughout the first several months of the postnatal period. Similarly, fetal astrocyte markers declined rapidly over this same time period ( Figure S2 ). This suggests that the relevant signaling cues responsible for astrocyte maturation likely occur during this critical developmental window. Therefore, we leveraged the ability of hCSs to be maintained for long periods in vitro and cultured hCSs for up to 590 days (20 months) to investigate whether we could capture this maturation process within our system ( Figure 2A ). We purified HepaCAM + cells from hCSs at multiple time points ranging from day 100 to day 590. We observed that immediately after dissociation into single cells, the morphologies of older hCS-derived HepaCAM + cells were more complex than those isolated at earlier time points ( Figure 2B ). This morphological complexity was maintained in monolayer culture and purified cells displayed a significant increase in the number of primary branches with increasing in vitro age (Figures 2C and 2D ; oneway ANOVA, F (5,143) = 15.68, p < 0.0001; n = 15-38 cells/ time point).
To investigate whether the morphological changes were consistent with transcriptome-level evidence of maturation, we performed RNA-seq on hCS-purified astrocyte lineage cells at each of the above time points. We then identified the top 100 most specifically enriched mature or fetal astrocyte genes from our primary datasets and used this 200-gene barcode as a benchmark of astrocyte maturation. When we chronologically ordered all hCS-derived astrocyte lineage samples from youngest to oldest, we observed a clear trend in the expression pattern of these 200 signature genes: hCS-derived astrocyte lineage cells from days 100-150 were predominantly enriched in the fetal astrocyte cassette of genes, whereas astrocytes from older hCSs, and particularly beyond day 250 in vitro, expressed higher levels of nearly all mature astrocyte genes (Figures 2E and 2F) . To better quantify the degree of maturation, we calculated correlation values for hCS-derived astrocytes with either primary fetal or mature human astrocytes. The correlation coefficients with mature primary astrocytes increased steadily with in vitro age of hCS-derived astrocytes, while the degree of fetal astrocyte correlation declined over the same time course ( Figure 2G , Spearman correlations). We then looked at the expression of individual fetal and mature astrocytes genes over time and observed similar trends in the gradual increase and decrease of mature and fetal genes, respectively ( Figure 2H ). Based on these data, we hereon refer to astrocyte lineage cells isolated from hCSs after 250 days of in vitro differentiation as mature hCS-derived astrocytes, as a respective comparison to those from earlier time points. Despite the close correlation between bulk hCS-derived HepaCAM + cells and primary adult astrocyte samples, we did observe some degree of separation between these two populations. The genes that contribute to this separation, and the respective gene ontological pathways that are specific to primary adult astrocytes versus hCS astrocytes after day 250 in vitro, can be found in Table S1 .
The well-established proliferative markers TOP2A and MKI67 are highly enriched in fetal astrocytes and steadily decrease with maturation. Previous work has demonstrated that fetal human astrocytes are highly proliferative as compared to mature astrocytes . To determine whether this functional difference was maintained across early and late hCS-derived astrocytes, we purified astrocytes from hCSs at various in vitro stages. After purification, the cells were grown in monolayer culture with the nucleoside analog 5-ethynyl-2 0 -deoxyuridine (EdU) to quantify the degree of cell proliferation. After 7 days, the percent of nuclei labeled with DAPI that had undergone at least one cell division declined from 34.9% ± 3.4% in day 167 hCSs to only 3.2% ± 2.6% in cells harvested from day 590 hCSs (Figures 2I and 2J; one-way ANOVA, F (5,11) = 49.48, p < 0.0001, n = 3 wells per condition). Interestingly, we noticed a slight discrepancy between the expression of mitotic markers (MKI67 and TOP2A) and the proliferation data, which could be related to differences between RNA and protein levels, sensitivity of the two cell proliferation assessments, or cell-culturerelated effects.
Single-Cell RNA-Seq of hCSs To obtain greater resolution into cell type identity and to capture the diversity of hCS-derived glial cells as they transition from fetal progenitors to a more mature state, we performed single-cell RNA-seq on individual cells from the same iPSC line across four different time points (in vitro differentiation days 100, 130, 175, and 450). At each of these time points, we dissociated hCSs into a single-cell suspension and collected both unsorted cells, as well as sorted astrocyte lineage cells, using anti-HepaCAM antibodies conjugated to fluorescein isothiocyanate (FITC) ( Figure 3A ). In total, we extracted sufficient RNA for cDNA library construction on 710 individual cells across these differentiation stages. To minimize batch effects, we collected single cells from multiple in vitro differentiation stages in the same sorting experiment, performed library generation on samples in tandem, and sequenced cells from multiple time points simultaneously. To cluster hCS-derived cells, we first identified over-dispersed genes to calculate a distance matrix for all cells and then used t-distributed stochastic neighbor embedding (t-SNE) dimensionality reduction to condense the data into a 2D space (van der Maaten and Hinton, 2008) (Supplemental Information). The (I) The proportion of the top 100 genes in clusters 1-3 that were enriched in adult astrocytes (orange, >4-fold expression increase in primary mature versus primary fetal astrocytes), fetal astrocytes (cyan, >4-fold expression increase in primary fetal versus mature primary astrocytes), or indeterminate (gray).
t-SNE plot minimizes the distance between cells with similar transcriptomic profiles in an arbitrary 2D space while maximizing the overall distance between populations. We observed two predominant clusters of cells within hCSs: one glial that specifically expressed the astrocyte-related marker SOX9 and one neuronal that included cells expressing the neuronal marker STMN2 (Figures 3B and 3C ). To take an unbiased approach toward classifying cells, we performed unsupervised hierarchical clustering, which separated the neuronal and glial populations along the same spatial segregation observed using t-SNE ( Figures 3D  and 3E ). As expected, the number of HepaCAM-isolated cells was greatly enriched in the glial population (95%), whereas the neuronal population was largely derived from unselected cells ( Figures S3A and S3B) . Moreover, the HEPCAM+ population contained only a small proportion of ventral RG-like cells (vRGs) as assessed by single-cell profiling and immunocytochemistry ( Figures S3C and S3D ). Within the STMN2 + population, we observed neurons expressing deep cortical layer markers (TBR1 and ETV1), as well as neurons expressing upper layer markers (SATB2 and TLE1). As expected, these upper layer markers were primarily derived from hCSs at later stages of in vitro differentiation ( Figure S3E ; Paş ca et al., 2015).
To further investigate astrocyte lineage cells, we performed unsupervised hierarchical clustering on the glial cell group. This analysis revealed three primary clusters of cells ( Figure 3F ), which correlated with in vitro differentiation stage ( Figure S3F ). For example, of the 40 glial cells derived from day 100 hCSs, 39 were assigned to cluster 1, whereas 41 out of 50 cells isolated from hCSs at day 450 were located in cluster 3 ( Figure 3G ). Cluster 1 contains cells expressing proliferation-related genes, such as TOP2A, NUSAP1, and UBE2C, while cluster 2 and cluster 3 include genes associated with progenitor cells (HOPX, PTPRZ1, and FAM107A) or mature astrocytes (ALDH1L1, AQP4, and AGT), respectively (the top enriched genes per cluster can be found in Table S2 ). The set of genes that define glial cluster 2 suggested overlap with the recently reported transcriptomic signature of human oRG (Pollen et al., 2015) . Therefore, we wondered whether cluster 2 cells might represent a glial lineage of oRGs within hCSs. We directly compared our single-cell RNAseq data from hCS-derived glia to single-cell data from fetal human brain tissue that was micro-dissected from the ventricular or subventricular zones around gestational weeks 16-18 (GW16-GW18) (Pollen et al., 2015) . To control for potential batch effects between these datasets, we normalized FPKMs for each cell via centering and scaling. The resulting t-SNE analysis separated clusters by cell type rather than by experimental origin ( Figures  S4A-S4C ). Subsequent unsupervised hierarchical clustering of hCS-derived glia and primary fetal ventricular/subventricular zone-derived glia produced three distinct clusters ( Figures S4D  and S4E ), which varied in their expression of maturation genes in a pattern similar to what was shown in Figure 3H ( Figure S4F ). We found that the ventricular zone-dissected primary cells (Pollen et al., 2015) were located almost exclusively within the most immature of these clusters (cluster 1), while subventricular zonedissected primary cells containing primary oRGs were almost all located in cluster 2. To examine the spatial distribution of oRGs within hCS cytoarchitecture, we performed immunohistochemistry on cross-sections of hCSs and observed expression of the oRG-related HOPX marker in the outermost region of the hCS proliferative zones ( Figure S4G ). Interestingly, none of the primary human fetal tissue cells from GW16-GW18 were found close to the most mature hCS glial cluster 3 ( Figures S4H and  S4I) , which was primarily comprised of hCS-derived astrocytes collected at 450 days of in vitro maturation.
These results prompted us to investigate how single-cell data collected from primary adult human brain tissue (Darmanis et al., 2015) might juxtapose with the t-SNE clustering of hCS-derived cells. Comparison to our hCS-derived cells revealed close association of adult primary astrocytes and neurons with respective glial and neuronal populations in hCS at late stages of in vitro differentiation ( Figures S5A-S5C) . We next performed Monocle analysis, which utlizes an unsupervised lineage algorithm to recover single-cell gene expression kinetics over a temporal process such as cell differentiation (Trapnell et al., 2014) . The intent of Monocle is to place cells in order of progress through a biological process without a priori knowledge of which genes to include. This analysis revealed two clear lineage paths (one neuronal and one glial), whose predicted pseudotime assignments matched closely with in vitro differentiation stages of hCSs ( Figures S5D and S5E) . We used this analysis to identify, in an unbiased manner, gene modules associated with astrocyte differentiation ( Figure S5F ; Table S3 ).
To further verify that cells belonging to the various astrocyte clusters reflect maturation states that have been identified in vivo, we correlated the degree of maturation within each population to our primary astrocyte data. We identified the top 100 most specific genes in each glial cluster (as determined from the Wilcoxon signed-rank test for each population) and calculated the enrichment (or depletion) of those genes in primary fetal or mature human astrocytes. We binned each gene into either a fetal (>4-fold enriched in fetal human astrocytes), mature (>4-fold enriched in mature human astrocytes), or unidentified category. We found that the majority of the genes that define the proliferating cluster 1 (83/100) were enriched in fetal astrocytes. This is in contrast to the mature astrocyte population (cluster 3) whose gene signature was defined predominantly by genes enriched in mature human astrocytes (82/100; Figure 3I ).
Stage-Dependent Functional Properties of hCS-Derived Astrocytes
To supplement the transcriptomic comparison to primary human astrocytes, we next asked whether hCS astrocyte lineage cells display functional physiological properties similar to what would be expected in vivo. In particular, we investigated the ability of hCS-derived HepaCAM-isolated cells to: (1) uptake glutamate via specific excitatory amino acid transporters, (2) phagocytose synaptosomes, (3) induce synapse formation in neurons, and (4) modulate calcium signaling in neurons.
One of the most accepted physiological roles for astrocytes in the CNS is the ability to recycle glutamate that is released at the synaptic cleft (Anderson and Swanson, 2000) . To investigate whether excitatory amino acid transporters (EAAT) mediate glutamate uptake in hCS astrocyte lineage cells, we purified HepaCAM + cells from hCSs at day 153 or day 419 and then incubated them with radioactive glutamate (L-[2,3,4- 3 H] glutamate) in the presence or absence of DL-threo-b-Benzyloxyaspartic acid (TBOA), a competitive non-transportable blocker of excitatory amino acid transporters ( Figure S6A ). These experiments showed uptake of glutamate in HepaCAM + cells that was significantly reduced by TBOA ( Figure S6B ; paired t test, p = 0.04). A more recent and intriguing finding about astrocytes is their ability to robustly phagocytose synapses in the rodent brain . Because synapse pruning has critical relevance to CNS development and disease pathophysiology (Penzes et al., 2011) , we asked whether hCS-derived astrocytes could also phagocytose synaptosomes in vitro. We purified synaptosomes from mouse brains by differential centrifugation (Dunkley et al., 2008) and labeled them with the fluorescent dextran pHrodoRed, a succinimidyl ester that is non-fluorescent until it is exposed to a low pH environment like the one in phagosomes. This is advantageous as it prevents quantification of synaptosomes that are simply adhering to the outside of cells. We incubated astrocytes purified from day 160 hCSs with pHrodoRed-labeled synaptosomes for 16 hr and imaged them every 15 min with an incubator-mounted system (Incucyte, EssenBiosciences). We observed robust phagocytic activity over this time period with numerous, distinct sites of (legend continued on next page) phagocytic uptake on hCS-derived astrocytes (Figures 4A-4C ; Figure S6C ; Movie S1). Additionally, we investigated whether synapse phagocytosis by hCS-derived astrocytes was occurring endogenously within hCSs during in vitro differentiation. We labeled glial cells within hCSs with a hGFAP::eGFP lentivirus and performed array tomography (AT) and immunostaining on ultra-thin cryosections (70 nm) for both presynaptic (SYN1) and postsynaptic markers (PSD95). Using synaptogram reconstructions ( Figure 4D ), we identified double-positive puncta for SYN1 and PSD95 within individual eGFP + processes of hCS-derived glia, suggesting that endogenous synaptic phagocytosis occurs within hCSs. We next asked whether astrocyte maturation state correlated with the cell-autonomous functional ability to phagocytose synaptosomes in vitro. We purified HepaCAM + cells from several differentiation time points spanning day 100 to day 590 in vitro ( Figure 4E ) and compared their ability to engulf pHrodoRed-labeled synaptosomes. We observed a significant decline in the quantity of phagocytosed synaptosomes as the age of the hCS-derived astrocytes increased (Figures 4F and 4G; one-way ANOVA, F (10,273) = 2.83, p = 0.002; n = 9 fields/ time point). Differences in morphology and arborization between hCS-derived astrocytes of different ages were accounted for by normalizing synaptosome engulfment to the total area of the cell (STAR Methods). This age-dependent decline in astrocyte phagocytosis is consistent with in vivo observations in mice . Thus, both mouse and human immature astrocytes display a higher phagocytic ability than mature astrocytes. In addition to synapse elimination, astrocytes also play a crucial synaptogenic role during CNS development. Therefore, we next asked whether hCS astrocyte lineage cells could induce synapse formation when cultured with retinal ganglion cells (RGCs) (Allen et al., 2012; Christopherson et al., 2005; Ullian et al., 2001) . RGCs can be cultured in defined media without astrocytes and therefore are commonly used as a model for assessing synapse formation. As seen in rodent and primary human astrocytes, we observed a robust induction of synapses when RGCs were cultured beneath an insert of hCS-derived astrocytes, which was relatively consistent in hCS-derived astrocytes isolated from 172 to 495 days in vitro (Figures 4H-4J ; RGCs with astrocytes: 14.2 ± 1.7 synapses/ field; RGCs without astrocytes 4.4 ± 0.9 synapses/field; twotailed t test, p = 0.006; mean ± SEM, Figure S6D ). These data suggest that the decreased phagocytic activity in older hCS-derived astrocytes is unlikely to be a result of decreased cell health, as older hCS-derived astrocytes demonstrated similar synaptogenic properties as astrocytes from younger time points.
Finally, we investigated whether the maturation of hCSderived astrocyte lineage cells can influence neuronal function. We tested whether depolarization-induced calcium signaling in immature hCS-derived neurons at early in vitro stages was affected by the presence of hCS astrocyte lineage cells isolated at early versus late stages of differentiation ( Figure 4K ). We dissociated human neurons from early hCSs (day 83 of differentiation), infected them with a viral reporter (AAV-DJ, hSyn1::mCherry), and co-cultured them in monolayer with HepaCAM-isolated cells from hCSs of three in vitro stages: days 117-128, days 232-238, or days 379-437. We then performed calcium imaging using the ratiometric dye fura-2 and found a significant (66%) increase in the peak [Ca 2+ ] i amplitude after depolarization in Syn1 + neurons co-cultured with astrocytes isolated from hCSs at days 379-437 as compared to earlier time points ( Figures 4L and 4M , one-way ANOVA; F (2, 126) = 15.69, p < 0.0001; post hoc Bonferroni for days 379-437 versus the other two time points, ***p < 0.001, ****p < 0.0001). This effect was also present when analyzing all the cells responding to depolarization and not just the more mature Syn1 + cells (Figure S6E , one-way ANOVA; F (2, 654) = 121.8, p < 0.0001; Bonferroni post hoc test, ****p < 0.0001).
DISCUSSION
The prolonged time course of human astrogenesis over the first years of life poses an experimental challenge to studying their development and function. We generated astrocyte lineage cells from iPSCs in 3D cerebral cortical cultures and maintained them for very long periods of time in vitro (up to 20 months in this study). We found that hCS-derived astrocytes closely resemble primary in vivo human astrocytes in their transcriptional landscapes. Moreover, hCS-derived astrocyte lineage cells display key functional characteristics of astrocytes in vivo: they uptake glutamate, promote synapse formation, phagocytose synaptsosomes, and augment depolarization-induced calcium signaling in neurons. Lastly, this human 3D culture system is using directed differentiation of iPSCs, allows easy maintenance of long-term cultures without significant reactive gliosis, and requires no exogenous factors for coaxing astrogenesis in vitro. In addition to enabling fundamental studies of human astrocyte development and function, this preparation has the potential to be a powerful method for elucidating the pathways that promote human astrocyte maturation. Once these pathways are better understood, it may be possible in the future to more rapidly generate human astrocytes in vitro.
In vivo maturation of astrocytes involves the progression of fetal APCs to mature, adult astrocytes. A fundamental question is to what extent such a transition could be observed in vitro and what functional features are associated with this progression. We observed evidence of maturation in hCS-derived astrocytes in 590-day-long in vitro cultures using direct comparison to primary fetal and adult human astrocytes. From a morphological standpoint, astrocyte branching within hCSs and after isolation, in monolayer, are more complex with increasing in vitro stage. At the transcriptional level, early-stage hCS astrocytes resemble human APCs, whereas late-stage hCS astrocytes resemble more mature astrocytes. Additionally, single-cell analysis of hCSs over multiple in vitro stages revealed a similar temporal progression of astrocyte maturation that involves three states: an actively proliferating population, an intermediate stage, and a mature, non-mitotic population that together comprise a continuum from RGs to APCs and eventually to mature astrocytes. There has been recent discussion regarding the similarities and differences between APCs and oRGs (Pollen et al., 2015; Zhang et al., 2016) due to the considerable overlap in their transcriptional profiles. We found that primary oRGs are similar at the single-cell transcriptional level to the intermediate cluster in hCS-derived HepaCAM + cells. Future studies, including fatemapping analyses, could elucidate this relationship and bring insights into cortical astrogenesis in humans. What controls the prolonged timing of human astrocyte maturation? Astrocyte maturation may be governed by numerous factors, including non-cell-autonomous paracrine signals, extrinsic hormonal signals, and/or intrinsic regulation of cell states. Our study offers clues about this process and will be a useful tool for additional studies aimed at understanding the maturation process. Despite an environment that differs considerably from the developing fetal human cortex, astrocyte lineage cells within hCSs mature along a similar time course to what is suggested from primary human data. Furthermore, our findings that astrocytes are maturing in hCSs without blood vessels or other vascular signals suggest either that some of the extrinsic cues for astrocyte maturation are of neural origin and/or that a cell intrinsic signal is responsible for their maturation. Although considerable astrocyte maturation occurs in our cultures, it is not complete, suggesting the possibility for future research that missing cell types, such as microglia or endothelial cells, may contribute to this process. The ability to generate mature human iPSC-derived astrocytes in vitro may contribute to the development of strategies for accelerating in vitro maturation of neurons and astrocytes, as well as to understanding the role in human CNS disorders of the cellular programs underlying this transition.
What are the functional consequences of astrocyte maturation? In mice and humans, both astrocytes and microglia actively participate in synaptic pruning during development Stevens et al., 2007) . In the mouse, the rate of astrocyte synaptic phagocytosis is high in the first postnatal week but then steadily declines as astrocytes mature and stop dividing by about postnatal day 10 (P10) . Strikingly, we also found that more mature human astrocytes are less efficient at phagocytosing synaptosomes compared to younger, fetal astrocytes. A similar phenomenon was also recently observed in vivo in mice, where astrocyte synaptic phagocytosis declined steadily from P4 to P9 during the peak of murine astrocyte maturation . This decline in synapse phagocytosis could be due to a decrease in available synaptic targets to prune or a cell-autonomous mechanism. When we looked at the expression of phagocytic genes in hCS astrocyte lineage cells over time, we found that MERTK is not expressed until human astrocytes mature, whereas MEGF10 is expressed at both ages but significantly increases upon astrocyte maturation. Interestingly, however, the expression of SIRPa, a membrane receptor that strongly inhibits phagocytosis and recognizes the ''don't eat me'' signal CD47 (Barclay and Van den Berg, 2014) , which is highly concentrated at synapses, is significantly upregulated when astrocytes mature. It is possible that the progressive increase in the expression of SIRPa or other phagocytic inhibitors on maturing astrocytes could contribute to reduced phagocytic abilities in these cells, and future studies should explore the role of microglia in modulating this process.
The transition from APCs to mature astrocytes has direct relevance to the fatal astrocytic brain tumor glioblastoma multiforme (GBM). Transcriptome profiles of neoplastic cells harvested from patients with GBM are highly correlated with APCs , suggesting that these tumors are largely comprised of fetal-like astrocytes proliferating uncontrollably. Whereas most failed therapeutic attempts to limit GBM progression have focused on restricting vascular supply and/or destroying proliferating cells, new opportunities arise for therapies that address astrocyte maturation/de-differentiation within GBMs. Exploring the detailed molecular pathways underlying astrocyte maturation within hCSs could provide new targets for modulating the transition within GBM tumors from an APC-like proliferative state to a mature, more quiescent phenotype.
Finally, recent work is beginning to implicate abnormal astrocyte development and function in various neurodevelopmental conditions, including autism spectrum disorders and schizophrenias (Ballas et al., 2009; Molofsky et al., 2012; Sloan and Barres, 2014) . Because many of the genes involved in synaptogenic and synapse pruning pathways are tightly correlated with astrocyte maturation state, it is possible that the development of abnormal neural circuits in various neurodevelopmental disorders may be related to the inappropriate timing and/or degree of astrocyte maturation.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
STAR+METHODS KEY RESOURCES TABLE
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Sergiu Paş ca (spasca@stanford.edu).
EXPERIMENTAL MODELS AND SUBJECT DETAILS Human iPSC Lines
All human stem cell work was performed with approval from the Stanford Human Stem Cell Research Oversight (SRCO) committee. Human iPSC lines were derived from fibroblasts harvested under informed consent and IRB approval. A total of four human iPSC lines derived from fibroblasts collected from three healthy subjects were used for experiments (two males and one female). Lines were characterized as previously described (Birey et al., 2017; Paş ca et al., 2011; Yazawa et al., 2011) and maintained on inactivated mouse embryonic fibroblast feeders as detailed below. Cultures were regularly tested for and maintained in Mycoplasma free conditions.
Fetal and Adult Primary Human Samples
Data from primary human samples were generated in Zhang et al. (2016) . Human brain tissue was obtained under a protocol approved by the Stanford University Institutional Review Board. The tissue was processed as previously described . In total, tissue from 27 individuals was used in this study (13 female and 14 male). Gender information for each sample can be found in the Table S4 from Zhang et al. (2016) .
METHODS DETAILS
Generation of hCSs hCSs were generated as previously described (Paş ca et al., 2015) . Briefly, iPSC colonies were enzymatically detached from inactivated mouse feeders in order to maintain intact colonies, and were subsequently transferred into low-attachment plates in a KnockOut Serum based media without fibroblast growth factor 2 (FGF2). Neural induction was achieved with small molecule inhibition of BMP (dorsomorphin, also known as compound C) and TGF-b (SB-431542) signaling pathways (Chambers et al., 2009 ). On day six in suspension, the floating spheroids were moved to serum-free Neurobasal with B-27 medium containing FGF2 and epidermal growth factor (EGF). Media was changed daily for the first 10 days and every other day for the subsequent 9 days. To promote differentiation, FGF2 and EGF were replaced with BDNF and NT3 starting at day 25, while from day 43 onwards only Neurobasal with B-27 without growth factors was used for medium changes every four days. hCSs derived from four iPSC lines/clones (8858-1, 8858-3, 1205-4 and 2242-1) differentiated in 33 independent experiments were used for the various assays.
Purification of hCS-Derived Astrocytes and Neurons
For a detailed purification protocol, see Supplemental Information. Briefly, 3-15 hCSs were used for each sample. The tissue was chopped using a #10 blade and then incubated in 30 U/ml papain at 34 C for 90 minutes and washed with a protease inhibitor stock solution. After digestion, the tissue was triturated and then the resulting single cell suspension was added to a series of plastic petri dish pre-coated with cell type specific antibodies and incubated for 10-30 minutes each at room temperature. Unbound cells were transferred to the subsequent petri dish while the dish with bound cells was rinsed with PBS to wash away loosely bound contaminating cell types. The antibodies used include anti-Thy1 (CD90) (R&D, MAB7335) to harvest neurons, anti-HepaCAM (R&D, MAB4108) to harvest astrocytes. For RNA-seq, cell samples were scraped off the panning dish directly with Qiazol reagent (Qiagen). For cell culture and in vitro experiments, astrocytes or neurons bound to the antibody coated dishes were incubated in a trypsin solution or accutase at 37 C for 3-5 minutes and gently squirted off the plate. We then spun down the cells and plated them on poly-D-lysine coated plastic coverslips in a Neurobasal/DMEM based serum-free medium (detailed in Supplemental Information). We replaced half of the volume with fresh medium every 3-4 days to maintain the cultures. Fetal human astrocytes and neurons were purified in a similar protocol to the above-mentioned procedure with the modifications detailed in the Supplemental Information.
Bulk RNA-Seq Library Construction and Sequencing Immediately after immunopanning, cells were scraped from each plate to harvest RNA and to minimize the delay between the initial dissociation of the hCSs and RNA isolation (3 hours). Total RNA was extracted using the miRNeasy kit (Qiagen) under the protocols of the manufacturer. The quality of the RNA was assessed by Bioanalyzer. Samples with integrity number higher than 8 were used for library construction. We used the Ovation RNA-seq system V2 (Nugen 7102) to perform first and second-strand cDNA synthesis. We then used the Next Ultra RNA-seq library prep kit for Illumina (NEB E7530) and NEBNext multiplex oligos for Illumina (NEB E7335 E7500) to perform end repair, adaptor ligation, and 5-6 cycles of PCR enrichment according to manufacturer's instructions. The quality of the libraries was assessed by bioanalyzer and qPCR and high quality libraries were sequenced by the Illumina NextSeq sequencer to obtain 75bp pair-end reads (41.0M ± 5.9M reads per sample, 80.6% ± 3.7% mapped; mean ± SD). All data have been deposited into GEO database (GEO: GSE99951).
Bulk RNA-Seq Read Mapping, Transcript Assembly, and Expression Level Estimation The FASTQ files were first groomed using the FASTQ groomer and then mapped using TopHat2, which invokes Bowtie as an internal read mapper. The paired end option was selected and human genome version 19 (hg19) was used as the reference genome. We then ran Cufflinks to assemble transcripts and estimate expression level as fragments per kilobase of transcript sequence per million mapped fragments (FPKM).
Single-Cell cDNA Synthesis and Library Preparation
Reverse transcription (RT) and PCR amplification was performed using the Smart seq2 protocol, described in Picelli et al. (2014) . Briefly, 96-well plates containing single-cell lysates were thawed on ice followed by incubation at 72 o C for 3 minutes and placed immediately on ice. Reverse transcription was carried out after adding 6 ml of RT-mix (100U SMARTScribe Reverse Transcriptase (TAKARA BIO), 10U Recombinant RNase Inhibitor (TAKARA BIO), 1X First-Strand Buffer (TAKARA BIO), 8.5 mM DTT (Invitrogen), 0.4 mM Betaine (Sigma), 10 mM MgCl 2 (Sigma) and 1.6 mM TSO (5 0 -AAGCAGTGGTATCAACGCAGAGTACATrGrG+G-3 0 )), for 90 minutes at 42 o C, followed by 5 minutes at 70 o C. RT was followed by PCR amplification. PCR was performed using 15 ml of PCR-mix (1x KAPA HiFi HotStart ReadyMix (Kapa Biosystems), 0.16 mM ISPCR oligo (5 0 -AAGCAGTGGTATCAACGCAGAGT-3 0 ) and 0.56U of Lambda Exonuclease (NEB) using the following thermal-cycling protocol: (1) C for 5 minutes. PCR was followed by bead purification using 0.7x AMPure beads (Beckman Coulter), capillary electrophoresis and smear analysis using a Fragment Analyzer (AATI). Calculated smear concentrations within the size range of 500 and 5000 bp for each single cell were used to dilute samples for Nextera library preparation as described in Darmanis et al. (2015) .
Single-Cell RNA Sequencing and QC In total, we sequenced 710 single cells using 75bp long paired end reads on a NextSeq instrument (Illumina) using High-output v2 kits (Illumina). Raw reads were preprocessed and aligned to the human genome (hg19) using the pipeline described in Darmanis et al. (2015) . As a quality metric, we first performed hierarchical clustering on all cells using a list of housekeeping genes, and removed any cells with uniformly low expression across all genes (likely a result of low quality RNA or cDNA synthesis). We separated the resulting dendrogram into two clusters containing cells that passed or failed this quality control (QC). All downstream analyses were performed using only the cells that passed QC (n= 710).
Dimensionality Reduction, Clustering, and Monocle Analysis All data analysis was performed using the R software (https://www.r-project.org/). Dimensionality reduction was performed in three steps. First, we calculated the overdispersion of each gene as described in Fan et al. (2016) . We then selected the top 1000 overdispersed genes and constructed a cell-to-cell distance matrix (1-absolute correlation) of all cells (using either hCS alone, primary cells from Pollen et al., 2015 or primary cells from Darmanis et al., 2015) . The distance matrix was reduced to two dimensions using t-SNE (van der Maaten and Hinton, 2008) . Clustering of groups of similar cells was performed on the two-dimensional t-SNE space using k-means. The lineage tree for the single-cells was constructed using the Monocle algorithm (updated 2.0 version) as described in Trapnell et al. (2014) . The lineage trees included all hCS single cells as well as the primary adult single cells from Darmanis et al. (2015) .
Live/Dead Assay hCSs were dissociated as described above. Immediately after dissociation, the single cell suspension was mixed with Calcein-AM (which fluoresces green after ester hemolysis in live cells) and Ethidium homodimer-1 according to manufacturer's instructions (Live/ Dead Viability/Cytotoxicity kit, Invitrogen, L3224).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean ± S.E.M., unless otherwise indicated. Distribution of the raw data was tested for normality of distribution. Statistical analyses were performed using the Student's T-test, the ANOVA with post-hoc tests or non-parametric tests, such as the Mann-Whitney U-test, when data was not normally distributed. Specifics on the type of test applied for each experiment are included in the figure legends and results section. Sample sizes were estimated empirically or based on power calculations. In general, n values refer to the number of individual lines, differentiations, or imaging fields for a given experiment; details are provided for each experiment in the corresponding figure legend. Blinding was used for analyses comparing samples from different lines and time-points.
DATA AND SOFTWARE AVAILABILITY
Gene expression data are available in the Gene Expression Omnibus, GEO: GSE99951.
The data that support the findings of this study are available on request from the corresponding author.
